← Back to Search

Home Blood Pressure Monitoring for High Blood Pressure (TB-HBPM Trial)

N/A
Recruiting
Led By Kevin Fiscella, MD, MPH
Research Sponsored by University of Rochester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Current HFM patient 18-85 years of age with hypertension diagnosis
At least one HFM health visit and hypertension diagnosis beginning no later than 7/1/2021.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 48 months participation
Awards & highlights

TB-HBPM Trial Summary

This trial will help identify strategies for implementing and sustaining team-based home blood pressure monitoring (TB-HBPM) in primary care settings, in order to improve hypertension control rates.

Who is the study for?
This trial is for adults aged 18-85 with high blood pressure who are patients at participating practices. It includes practice employees involved in hypertensive patient care. People with dementia, end-stage renal disease, hospice care, or current pregnancy cannot join.Check my eligibility
What is being tested?
The study tests a team-based home blood pressure monitoring program that lets patients send their readings to their health teams and receive coordinated hypertension care including education and monthly feedback.See study design
What are the potential side effects?
Since this intervention involves monitoring and educational strategies rather than medication, it does not have the typical side effects associated with drug treatments.

TB-HBPM Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 85 years old with high blood pressure.
Select...
I was diagnosed with high blood pressure and saw a doctor for it by July 1, 2021.
Select...
I work with patients with high blood pressure, involved in their care or treatment.

TB-HBPM Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~beginning with the 6-month intervention period and up to 48 months participation
This trial's timeline: 3 weeks for screening, Varies for treatment, and beginning with the 6-month intervention period and up to 48 months participation for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Blood pressure control
Secondary outcome measures
Blood pressure control by insurance
Blood pressure control by race and ethnicity
Chronic disease self-management capacity (QICA)
+4 more
Other outcome measures
Anti-hypertensive medication intensification
Bronchial Provocation Tests
Hypertensive disease
+5 more

TB-HBPM Trial Design

3Treatment groups
Experimental Treatment
Group I: Suite TB-HBPM throughout intervention implementationExperimental Treatment1 Intervention
Each suite will be randomized to implement the TB-HBPM program during one of three wedges separated by six months between each, 1.5 years later.
Group II: Suite TB-HBPM pre interventionExperimental Treatment1 Intervention
Each suite/cluster throughout the institution will begin in the baseline usual care phase in the first year.
Group III: Suite TB-HBPM post intervention implementationExperimental Treatment1 Intervention
Post implementation phase of the suites 2 years after introduction of intervention.

Find a Location

Who is running the clinical trial?

University of RochesterLead Sponsor
836 Previous Clinical Trials
512,408 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,696 Previous Clinical Trials
6,946,819 Total Patients Enrolled
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,834 Previous Clinical Trials
47,303,735 Total Patients Enrolled

Media Library

Team-Based Home Blood Pressure Monitoring Clinical Trial Eligibility Overview. Trial Name: NCT05488795 — N/A
High Blood Pressure Research Study Groups: Suite TB-HBPM post intervention implementation, Suite TB-HBPM pre intervention, Suite TB-HBPM throughout intervention implementation
High Blood Pressure Clinical Trial 2023: Team-Based Home Blood Pressure Monitoring Highlights & Side Effects. Trial Name: NCT05488795 — N/A
Team-Based Home Blood Pressure Monitoring 2023 Treatment Timeline for Medical Study. Trial Name: NCT05488795 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What qualifications do potential participants require in order to join this trial?

"This research project is recruiting 5760 individuals with hypertension, and they must be aged between 18 to 85. Most notably, these patients need to meet the following requirements: They have a job in healthcare management (e.g., practice leaders, administrators, clinicians or staff) related to hypertensive care; current patient of HFM who was diagnosed before July 1st 2021 according ICD-10 codes I10-I14; had at least one visit for blood pressure checkup at an HFM health centre prior to 7/1/2021."

Answered by AI

What is the current enrollment count for this research effort?

"Affirmative. According to clinicaltrials.gov, this investigation is currently recruiting participants. Initially posted on August 1st 2022 and last amended on the subsequent day, it seeks 5760 patients from a single medical centre."

Answered by AI

Are participants currently being sought out for this experiment?

"According to the information hosted by clinicaltrials.gov, this medical experiment is actively recruiting participants; it was first posted on August 1st 2022 and recently modified on August 2nd of the same year."

Answered by AI

Does this research endeavor accommodate elderly participants?

"As indicated in the trial requirements, this clinical experiment accepts participants aged between 18 and 85. For minors (under 18) there are 54 studies they can apply for while seniors (over 65) have access to 661 different trials."

Answered by AI
~2444 spots leftby Jul 2025